Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSKTetsuya Toge, Takao Hattori, Etsuro Yanagawa et al.|International Journal of Immunopharmacology|1989Cited by 15
The clinical efficacy of intratumoral OK-432 administration in advanced cancer patientsTetsuya Toge, Takao Hattori, H Kuninobu et al.|Surgery Today|1988Cited by 6
Effects of the oral or intratumoral administration of OK432 on the immuno-reactivities of regional lymph nodes in gastric cancer patientsEtsuro Yanagawa, Yukio Sato, Tetsuya Toge et al.|Surgery Today|1991Cited by 2
Interference of the induction of suppressor cells by a streptococcal preparation, OK-432 through the blocking of suppressor inducer T-cellsTetsuya Toge, Etsuro Yanagawa, Katsumasa Kuroi et al.|International Journal of Immunopharmacology|1990Cited by 2
The regulation of natural killer cell activity by splenic nonspecific suppressor cells and its modification in cancer patientsEtsuro Yanagawa, Tetsuya Toge, Akihiro Sawamura et al.|Surgery Today|1988Cited by 2